vimarsana.com

Page 12 - Stefan Oschmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PRESSESPIEGEL/Unternehmen: BERTELSMANN, MERCK, SPARKASSEN, STEIGENBERGER

PRESSESPIEGEL/Unternehmen: BERTELSMANN, MERCK, SPARKASSEN, STEIGENBERGER
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

UPDATE 1-Germany s Merck boosts BioNTech lipid supply amid vaccine shortages

Merck KGaA liefert mehr Lipide für Biontechs Corona-Impfstoff

Merck KGaA liefert mehr Lipide für Biontechs Corona-Impfstoff
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Wie Stefan Oschmann Merck still und leise zum Überflieger gemacht hat

Wie Stefan Oschmann Merck still und leise zum Überflieger gemacht hat
faz.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from faz.net Daily Mail and Mail on Sunday newspapers.

Merck acquires AmpTec to expand mRNA capabilities

Industry News: Merck acquires AmpTec to expand mRNA capabilities for vaccines, treatments and diagnostics Diagnostics business focused on producing customized long RNAs and DNAs for in vitro diagnostics, complements existing Merck portfolio 11 Jan 2021 Merck, a leading science and technology company, has announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO). The deal strengthens Merck’s capabilities to develop and manufacture mRNA for its customers for use in vaccines, treatments and diagnostics applicable in Covid-19 and many other diseases. Financial terms were not disclosed. “The success of mRNA-based vaccines for Covid-19 lays the path to accelerate the development of these therapeutics for many other diseases,” said Stefan Oschmann, Chairman of the Executive Board and CEO of Merck. “By combining AmpTec’s PCR-based mRNA technology with Merck’s extensive expertise in lipids manufacturi

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.